[ET Net News Agency, 17 September 2025]  JD HEALTH (06618) rose 2.7% to HK$67.35. 
  It hits an intra-day high of HK$67.55, breaking above the 10-D SMA of HK$66.76, and an  
intra-day low of HK$65.6. The total shares traded was 2.37 million, with a value of 
HK$158.05m. The active buy/sell ratio is 56:44, with net buying turnover of HK$17.97m.  
CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of 
HK$4.71m, with volume weighted average price of HK$66.827. CLSA LTD accounts for greatest 
net responsive selling turnover of HK$8.36m, with volume weighted average price of  
HK$66.749.
  RMB counter of JD HEALTH (86618) rose 2.3% to RMB61.4.
  The Hang Seng Index now rose 232 points, or 0.9% to 26,670; the Hang Seng China 
Enterprises Index now rose 114 points, or 1.2% to 9,501; the Hang Seng TECH Index now rose
153 points, or 2.5% to 6,231. 
  
          Basic Information 
          ================= 
  
  ----------------------------------
  Nominal   67.350 % Chg     +2.75% 
  High      67.550 Low       65.600 
  Shares Tr  2.37m Turnover 158.05m 
  10-D SMA  66.760 %H.V      41.523 
  20-D SMA  65.265 VWAP      66.770 
  50-D SMA  56.842 RSI14     61.707 
  ----------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 56:44, with net buying  
turnover of HK$17.97m 
  
Performance of stocks in the same sector or of relevance
========================================================
  
  Stock (Code)          Price (HK$) Change (%)
  --------------------------------------------- 
  JD HEALTH (06618)           67.35      +2.75
  XIAOMI-W (01810)            57.15      +1.24
  MAOYAN ENT (01896)           8.41      -0.24
  JD LOGISTICS (02618)        13.85      +1.39
  SUNART RETAIL (06808)        2.02  Unchanged
  JD-SW (09618)              136.70      +5.15
  BILIBILI-W (09626)         211.80      -0.09
  BABA-W (09988)             159.10      +3.65
  NTES-S (09999)             244.80      +0.49
  JD HEALTH-R (86618)      RMB61.40      +2.33
  --------------------------------------------- 
  (ed)



 
 